Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05918237 · ClinicalTrials.gov registry record · NA
Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema
A NA study of Atopic Dermatitis Eczema, sponsored by ClinOhio Research Services.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05918237 is a NA study of Atopic Dermatitis Eczema that has completed, run by ClinOhio Research Services. The registered enrollment target is 30 participants, below the 198-participant average among 8 other Atopic Dermatitis Eczema trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05918237, a NA study of Atopic Dermatitis Eczema, has completed, sponsored by ClinOhio Research Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Up to 30 participants with mild to moderate atopic dermatitis/eczema will be enrolled to apply study Investigational Product for 4 weeks.
Conditions Studied
Interventions
- OTHER Arctiva
Study Locations (1)
Ohio
- ClinOhio Research Services, LLC - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-02-06 |
| Est. Completion | 2023-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05918237
The ClinicalTrials.gov registry entry for NCT05918237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 198-participant average among 8 other Atopic Dermatitis Eczema trials with a reported enrollment target (85% lower). The listed sponsor is ClinOhio Research Services, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atopic Dermatitis Eczema appearing as the primary indexed condition, and to 1 intervention - of which Arctiva is the first listed.
NCT05918237 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05918237 about?
NCT05918237 is a clinical study titled "Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema". Up to 30 participants with mild to moderate atopic dermatitis/eczema will be enrolled to apply study Investigational Product for 4 weeks.
What is the current status of trial NCT05918237?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-02-06. Estimated completion is 2023-04-28.
What conditions does trial NCT05918237 study?
This clinical trial studies the following conditions: Atopic Dermatitis Eczema.
What interventions are being tested in trial NCT05918237?
The interventions under investigation include: Arctiva (OTHER).
Who is sponsoring clinical trial NCT05918237?
This trial is sponsored by ClinOhio Research Services, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05918237 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis Eczema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
COMPLETED · NA
-
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
COMPLETED · NA
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
RECRUITING · Phase 2
-
Seal, Stopping Eczema and Allergy Study
ACTIVE NOT RECRUITING · Phase 2
-
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.